Clinical Trial Update: Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated erlotinib in patients with recurrent or metastatic colorectal cancer (including adenocarcinoma of the colon and rectum). T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Adenocarcinoma of the Rectum
• Colon Cancer
• Rectal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 2 | Status: COMPLETED